Skip to content
Betviplane

Zimbabwe Declines ‘Lopsided’ American Healthcare Assistance Deal Because of Data Fears

Medical funding image
The proposed American financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has declined a significant American healthcare agreement worth 367 million US dollars (272 million pounds) over five years over Washington's request for confidential information.

The decision became public following a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa deemed the deal was "lopsided".

An official spokesperson later explained that the United States was requesting health data for scientific study and commercial purposes but refused to share the benefits from future medical innovations.

"We will now turn to the difficult and regrettable task of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the United States had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has urged more negotiations to reach a deal agreeable to both sides so the country's critical HIV programme can continue.

Broader Context

This rejection comes after a similar situation in neighbouring Kenya, where a court blocked a similar deal with the US following legal challenges were filed about the safety of Kenyans' health data.

Since resuming office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

USAID had managed aid for the American government, but Trump claimed its spending was "inefficient" and his government was pursuing government-to-government agreements to boost transparency and responsibility.

According to reports, 16 African countries have to date signed similar health pacts, representing more than $18.3bn in committed funds.

Details of the Declined Agreement

The money for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this cooperation could have provided immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment through US-supported programmes," Tremont commented.

However, official spokesman Nick Mangwana maintained the arrangement was "unfair".

"Our nation was requested to provide its biological resources and data over an extended period, without any corresponding assurance of access to any medical innovations – such as new medicines or tests – that could result from that provided information," Mangwana explained.

"In essence, our country would supply the basic resources for medical research without any certainty that the end products would be accessible to our people should a new disease outbreak emerge."

Sovereignty and Global Health

He also pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting frameworks previously established via the international health agency.

Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to manage future global health emergencies.

"This mechanism is designed to guarantee that when a country provides its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."

Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We are open to further dialogue with our American counterparts on how subsequent co-operation might be designed in a way that respects the sovereignty and interests of each country."

Health Experts Reaction

A leading public health body said it acknowledged the government's concerns, but suggested that talks need to persist since much of the nation's Aids initiatives relied on foreign aid.

"If technical issues arise, including those involving data governance or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," it commented.

The halted deal underscores the ongoing debate between accepting crucial international aid and safeguarding a country's data in an ever more interconnected world.

By

Tyler Wallace

A seasoned travel writer with a passion for uncovering hidden gems and sharing practical advice for explorers worldwide.

Betviplane

Type to search articles.